Literature DB >> 17891657

Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.

Michael M Copenhaver1, R Douglas Bruce, Frederick L Altice.   

Abstract

There is growing empirical evidence of buprenorphine's effectiveness in treating opioid dependence in community-based settings in the U.S. Decades of research indicates that in order for buprenorphine to have a sizable effect, it must be appropriately supported by behavioral counseling. Studies to date have not established the optimal behavioral counseling content for supporting buprenorphine treatment. The objective of this article is: 1) to review evidence of the key treatment-relevant issues posed by opioid-dependent patients in community-based settings in the U.S.; and 2) to review behavioral counseling content that may optimize the use of buprenorphine for treating opioid dependence in such settings. Evidence points toward the use of behavioral counseling aimed at enhancing patients' motivation during treatment entry followed by an emphasis on improving coping/relapse prevention skills during the primary phase of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891657      PMCID: PMC2274830          DOI: 10.1080/00952990701522674

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  34 in total

1.  Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.

Authors:  Kathleen M Carroll; Rajita Sinha; Charla Nich; Theresa Babuscio; Bruce J Rounsaville
Journal:  Exp Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.157

Review 2.  Recent advances in the dissemination of contingency management techniques: clinical and research perspectives.

Authors:  Nancy M Petry; Francis Simcic
Journal:  J Subst Abuse Treat       Date:  2002-09

3.  Successfully integrating an HIV risk reduction intervention into a community-based substance abuse treatment program.

Authors:  Michael M Copenhaver; I-Ching Lee; Arthur Margolin
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

4.  Buprenorphine for opiate addiction: potential economic impact.

Authors:  R Rosenheck; T Kosten
Journal:  Drug Alcohol Depend       Date:  2001-08-01       Impact factor: 4.492

5.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

6.  One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment.

Authors:  K M Carroll; C Nich; S A Ball; E McCance; T L Frankforter; B J Rounsaville
Journal:  Addiction       Date:  2000-09       Impact factor: 6.526

7.  Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.

Authors:  Arthur Margolin; S Kelly Avants; Lara A Warburton; Keith A Hawkins
Journal:  AIDS Patient Care STDS       Date:  2002-06       Impact factor: 5.078

8.  Behavioral naltrexone therapy: an integrated treatment for opiate dependence.

Authors:  Jami L Rothenberg; Maria A Sullivan; Sarah H Church; Angela Seracini; Eric Collins; Herbert D Kleber; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2002-12

9.  Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

Authors:  K L Sees; K L Delucchi; C Masson; A Rosen; H W Clark; H Robillard; P Banys; S M Hall
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

10.  Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder.

Authors:  Marsha M Linehan; Linda A Dimeff; Sarah K Reynolds; Katherine Anne Comtois; Stacy Shaw Welch; Patrick Heagerty; Daniel R Kivlahan
Journal:  Drug Alcohol Depend       Date:  2002-06-01       Impact factor: 4.492

View more
  18 in total

1.  Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence.

Authors:  Ryan Schwarz; Alexei Zelenev; R Douglas Bruce; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2012-04-24

2.  Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.

Authors:  Britton A Gibson; Debarchana Ghosh; Jamie P Morano; Frederick L Altice
Journal:  Health Place       Date:  2014-05-21       Impact factor: 4.078

Review 3.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Authors:  Kathleen M Carroll; Roger D Weiss
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

4.  Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.

Authors:  Maureen Hillhouse; Catherine P Domier; David Chim; Walter Ling
Journal:  J Addict Dis       Date:  2010-01

5.  Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.

Authors:  Ali Shabahang Saber-Tehrani; Sandra A Springer; Jingjun Qiu; Maua Herme; Jeffrey Wickersham; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2011-11-12       Impact factor: 2.226

6.  HURRICANE CHANGES: EXAMINING ENHANCED MOTIVATION TO CHANGE DRUG USING BEHAVIORS AMONG KATRINA EVACUEES.

Authors:  Nelson Jose Tiburcio; Robert Twiggs; Eloise E Dunlap
Journal:  Anu Investig Adicciones       Date:  2009-12-01

7.  Participant characteristics and buprenorphine dose.

Authors:  Maureen Hillhouse; Catherine P Canamar; Geetha Doraimani; Christie Thomas; Albert Hasson; Walter Ling
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

8.  Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.

Authors:  Kamilla L Venner; Dennis M Donovan; Aimee N C Campbell; Dennis C Wendt; Traci Rieckmann; Sandra M Radin; Sandra L Momper; Carmen L Rosa
Journal:  Addict Behav       Date:  2018-05-23       Impact factor: 3.913

9.  Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.

Authors:  Sandra Ann Springer; Shu Chen; Frederick L Altice
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

10.  Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.